A Clinical trial to study the effects of two drugs, Gomutra triphala vati and Navaka guggulu in patients of sthoulya who are having overweight and obesity (class one) dividing them in two groups randomly and giving medicines for about one and half months

A Randomized Controlled Clinical Study to evaluate the efficacy of Gomutra Triphala vati in the management of Sthoulya.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/07/043980

Enrollment

Registered

2022-07-13

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E663- Overweight

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients having BMI ranging from 1 25 to 29.9 Kg/m2( Over weight ) 2 30 to 34.9 Kg/m2(Class one Obesity ) Associated with any two of the below mentioned features 1 Atikshudha 2 Atisweda 3 Atinidra 4 Alasya/ Utsaha hani 5 Atipipasa 6 Alpa shwasa 7 Daurgandhya 8 Chala Sphik ,Udara, Stana 9 Subjects who are ready to give written informed consent

Exclusion criteria

Exclusion criteria: 1 Subjects who are known case of Diabetes Mellitus, Hypertension, Ischemic Heart Disease or any other Systemic diseases. 2 Obese patients with known Endocrine Dysfunctions. 3 Pregnant women and Lactating mothers.

Design outcomes

Primary

Measure	Time frame
The effect of the treatment will be assessed based on detailed case proforma adopting standard scoring methods of subjective parameters such as Ã¢â?¬Â¢ Atikshudha Ã¢â?¬Â¢ Atisweda Ã¢â?¬Â¢ Atinidra Ã¢â?¬Â¢ Alasya/ Utsaha hani Ã¢â?¬Â¢ Atipipasa Ã¢â?¬Â¢ Alpa shwasa Ã¢â?¬Â¢ Daurgandhya Ã¢â?¬Â¢ Chala Sphik ,Udara, Stana and objective parameters such as Ã¢â?¬Â¢ Body Weight Ã¢â?¬Â¢ BMI Ã¢â?¬Â¢ Waist Hip ratio pre and post interventional assessment will be done.Timepoint: The effect of the treatment will be assessed before treatment on day 0, then during treatment on day 16, day 31,day 46 and after treatment follow up on day 61 total of 8 weeks	—

Measure

Time frame

The effect of the treatment will be assessed based on detailed case proforma adopting standard scoring methods of subjective parameters such as Ã¢â?¬Â¢ Atikshudha Ã¢â?¬Â¢ Atisweda Ã¢â?¬Â¢ Atinidra Ã¢â?¬Â¢ Alasya/ Utsaha hani Ã¢â?¬Â¢ Atipipasa Ã¢â?¬Â¢ Alpa shwasa Ã¢â?¬Â¢ Daurgandhya Ã¢â?¬Â¢ Chala Sphik ,Udara, Stana and objective parameters such as Ã¢â?¬Â¢ Body Weight Ã¢â?¬Â¢ BMI Ã¢â?¬Â¢ Waist Hip ratio pre and post interventional assessment will be done.Timepoint: The effect of the treatment will be assessed before treatment on day 0, then during treatment on day 16, day 31,day 46 and after treatment follow up on day 61 total of 8 weeks

—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr Susheel shetty

Alvas Ayurveda Medical College Moodbidri

shettysusheel13@gmail.com9980431676

Outcome results